Related Experiment Videos
Tau function and dysfunction in neurons: its role in neurodegenerative disorders
Jesús Avila1, Filip Lim, Francisco Moreno
1Centro de Biología Molecular (CSIC-UAM), Universidad Autónoa, Madrid, Spain. javila@cbm.uam.es
Molecular Neurobiology
|July 12, 2002
Summary
Alzheimer's disease (AD) is a common neurodegenerative disorder causing dementia. Its hallmark is neurofibrillary tangles (NFTs) made of abnormal tau protein tangles in the brain.
Area of Science:
- Neuroscience
- Pathology
- Gerontology
Background:
- Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder contributing to dementia in the elderly.
- AD pathology is defined by senile plaques and neurofibrillary tangles (NFTs) in the brain.
- Neurofibrillary tangles (NFTs) consist of aggregated, abnormally phosphorylated tau protein.
Purpose of the Study:
- To investigate the composition and formation of neurofibrillary tangles (NFTs) in Alzheimer's disease (AD).
- To understand the role of abnormal tau phosphorylation in AD pathogenesis.
- To explore potential therapeutic targets related to tau pathology in AD.
Main Methods:
- Immunohistochemistry to detect tau pathology in brain tissue.
- Biochemical assays to analyze tau protein phosphorylation.
- Microscopy techniques to visualize fibrillar tau polymers.
Main Results:
- Confirmed NFTs are primarily composed of abnormally phosphorylated tau protein.
- Demonstrated the aggregation of tau into fibrillar polymers within NFTs.
- Established a link between tau hyperphosphorylation and tangle formation.
Conclusions:
- Abnormal tau phosphorylation is a critical step in the formation of neurofibrillary tangles (NFTs) in Alzheimer's disease (AD).
- Tau pathology, specifically NFTs, is a key characteristic of AD.
- Targeting tau phosphorylation may offer a therapeutic strategy for AD.